-
News
U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition
Phase 2 clinical trial underway for Hypoplastic Left Heart Syndrome, which affects approximately 1,000 babies per year Miami, Florida—November 18th,…
Read More » -
CORRECTION: SMG Industries, Inc. Reports 2021 $14.77 Million Revenue Third Quarter and $34.61 Million for the Nine Month Financial Results
[ad_1] Houston, Texas – (NewMediaWire) – November 17, 2021 – SMG Industries, Inc. (the “Company”) (OTCQB:SMGI), a growth-oriented transportation services…
Read More » -
News
NextPlay Launches NextPlay X Soma Labs, an Innovation and Design Lab for Non-Fungible Tokens (NFTs), Social Games, and Metaverse Worlds
[ad_1] Sunrise, FL – (NewMediaWire) – November 17, 2021 – NextPlay Technologies, Inc. (NASDAQ: NXTP) (the “Company”), a digital business ecosystem…
Read More » -
News
Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint
Pasithea Clinics to offer ketamine infusion therapy for the treatment of mental health disordersFirst mobile clinics launch in New York…
Read More » -
Featured
SusGlobal Energy Corp.: A Sustainable Solutions Provider To Environmental Waste
The demand for organic fertilizers has been increasing significantly over the years as nearly 33% of the world’s adequate or…
Read More » -
Update: Todos Medical Reports Third Quarter 2021 Business and Financial Results
[ad_1] New York, NY, and Tel Aviv, ISRAEL – (NewMediaWire) – November 16, 2021 – Todos Medical, Ltd. (“Todos Medical”) (OTCQB:…
Read More » -
News
Tauriga Sciences, Inc. Confirms the Commercial Launch of its New Kosher Certified by Orthodox Union
[ad_1] New York, NY – (NewMediaWire) – November 16, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a…
Read More » -
News
Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT
NEW YORK, NY November 16, 2021/PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has signed a…
Read More »
